Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,959.00
Bid: 1,961.00
Ask: 1,962.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.051%)
Open: 1,958.00
High: 1,969.00
Low: 1,950.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Pandemic fears pummel European stocks into correction territory

Thu, 27th Feb 2020 09:58

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Travel and leisure, basic resources stocks worst hit

* WPP leads losses on STOXX 600 after bleak forecast

* Standard Chartered, AB InBev latest victims of virus
damage

* Hikma Pharma tops STOXX 600 on annual earnings beat
(Adds details, updates to close)

By Ambar Warrick and Thyagaraju Adinarayan

Feb 27 (Reuters) - European stocks marked their weakest
close in more than four months on Thursday, sinking into
correction territory as a jump in coronavirus cases outside
China deepened fears of an economically damaging pandemic.

Investors typically consider a correction in a security or
index to be a drop of 10% or more from its recent peak.

The pan-European STOXX 600 index, which retreated
3.8% for the day, has fallen more than 10% from a record high
hit on Feb. 19.

While strong earnings had caused investors to pause selling
on Wednesday, a spike in infections outside China, particularly
in Italy, saw markets slip back into red.

"From the unshakeable optimism seen at the beginning of the
year, investors have done a complete U-turn switching from
excessive optimism to outright pessimism in less than a week,"
Michael Hewson, chief market analyst at CMC Markets UK, said.

Thursday's sell-off saw more than 97% of the pan-European
STOXX 600 index's constituents trading red, with basic
resources stocks among the worst performers as commodity
prices plunged amid fears of sustained disruptions in the global
supply chain.

"The sell-off in the base metals complex over the last few
days largely reflects the heightened risk-off sentiment or
'fear-factor' across broader riskier assets," Wenyu Yao, senior
commodities strategist at ING wrote in a note.

London-listed miner Evraz Plc was the worst
performing stock in the sector after it posted weak 2019
earnings.

Travel stocks also plummeted, with casino operator
Evolution Gaming Group leading declines. The sector
has shed nearly 15% this week, underperforming its peers by a
wide margin.

Standard Chartered fell 3.5% after the bank said a
key earnings target would take longer to meet as the epidemic
adds to headwinds in China and Hong Kong. The broader bank
sector was also pressured by a drop in bond yields.

The world's largest beer maker, Anheuser-Busch InBev
, plunged nearly 11% after it forecast muted growth in
2020, due in part to the outbreak.

Advertising major WPP tumbled 16%, marking its worst
day since August 1992, after saying it would target flat organic
growth and profit margins in 2020. The stock was the worst
performer on the STOXX 600.

Italian shares, which entered correction territory
on Wednesday, fell 2.7% as the country reported another 100
coronavirus cases nationwide, taking the total to more than 400.

In a sole bright spot, Hikma Pharmaceuticals rose
4.6%, topping the STOXX 600 after it beat expectations with its
annual earnings.
(Reporting by Sruthi Shankar in Bengaluru and Danilo Masoni in
Milan
Editing by Sriraj Kalluvila, Giles Elgood and Frances Kerry)

More News
25 Feb 2021 08:02

UPDATE 2-UK's Hikma misses profit estimate, disappoints on 2021 outlook, share tumbles

* Core operating profit of $566 mln vs consensus of $574 mln* 2021 outlook weaker than analyst expectation* Shares drop nearly 7% (Recasts, adds shares, CEO and analyst comments)By Tanishaa Nadkar and Pushkala AripakaFeb 25 (Reuters) - Hikma Pharmac...

Read more
25 Feb 2021 08:01

LONDON MARKET PRE-OPEN: ABF's Primark Loses GBP1.1 Billion In Sales

LONDON MARKET PRE-OPEN: ABF's Primark Loses GBP1.1 Billion In Sales

Read more
18 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
15 Feb 2021 09:40

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

Read more
3 Feb 2021 09:17

UPDATE 2-Healthcare drags FTSE 100 down; Vodafone jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* GlaxoSmithKline slumps on COVID-19 vaccine development* Vodafone gains after earnings beat estimates* Glencore rises after maintaining 2021...

Read more
1 Feb 2021 13:44

Monday broker round-up

(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.

Read more
26 Jan 2021 08:28

TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia

TOP NEWS: Hikma In Talks To Buy Glaxo Businesses In Egypt And Tunisia

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
2 Dec 2020 13:11

Wednesday broker round-up

(Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.

Read more
24 Nov 2020 13:33

Tuesday broker round-up

(Sharecast News) - Glencore: Jefferies upgrades to buy with a target price of 250p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.